Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8367628 Amphoteric liposome formulation

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Gerold Endert0

Natalie Herzog0

Neal Clifford Goodwin0

Steffen Panzner0

Wendi Rodrigueza0

Yvonne Kerwitz0

Date of Patent

February 5, 2013

0

Patent Application Number

120858930

Date Filed

December 1, 2006

0

Patent Citations Received

US Patent 11752238 Recapitulating the hematopoietic niche to reconstitute immunity

US Patent 11998593 Combination vaccine devices and methods of killing cancer cells

0

US Patent 11926831 SiRNA structures for high activity and reduced off target

0

US Patent 11786457 Peritumoral and intratumoral materials for cancer therapy

Patent Primary Examiner

James (Doug) Schultz

0

Patent abstract

The invention relates to compositions and methods to inhibit gene expression. In particular, the invention provides DNAi oligonucleotides sequestered by amphoteric liposomes for the treatment of cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8367628 Amphoteric liposome formulation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool